Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 15;14(1):138.
doi: 10.1186/s12916-016-0685-4.

The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality

Rebecca C Harris  1 , Peter J Dodd  2 , Richard G White  3
Affiliations

The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality

Rebecca C Harris et al. BMC Med. .

Abstract

Background: The Bacillus Calmette-Guérin (BCG) vaccine is provided to over 100 million neonates annually to protect against childhood tuberculosis (TB). Recent BCG manufacturing interruptions highlight global supply risks. We estimated the potential impact of BCG shortfalls on global paediatric (<15 years) TB mortality.

Methods: A static mathematical model was employed to estimate the number of paediatric TB deaths avoided by usual levels of BCG coverage, and potential additional TB deaths in the first 15 years of life due to 1-year BCG supply shortfalls of 6.3 % (as occurred in 2015) to 27.6 % (as anticipated without mitigating action in 2015) assuming no catch-up campaigns.

Results: BCG coverage without shortfalls, estimated at 90 % globally, was estimated to avoid 117,132 (95 % uncertainty range (UR): 5049-306,911) TB deaths globally per birth cohort in the first 15 years of life. An estimated 11,713 (UR: 505-30,691) additional TB deaths would occur in the first 15 years of life per 10 % (26 million dose) annual supply shortfall. A 16.5 million dose (6.3 %) shortfall as reported at the close of 2015, reflecting 84 % global coverage, was estimated as associated with 7433 (95 % UR: 320-19,477) excess TB deaths in the affected cohort in the first 15 years. A possible 24,914 (UR: 1074-65,278) additional deaths were avoided due to prompt shortfall reduction measures in 2015.

Conclusions: BCG shortages could greatly increase paediatric TB mortality. Although rapid action in 2015 minimised BCG shortfalls, avoiding a large number of potential additional deaths, the possible public health impact of even relatively small shortfalls highlights the critical importance of ensuring secure future manufacturing capacity and global BCG supply continuity.

Keywords: Bacillus Calmette-Guérin vaccine; Child; Mathematical model; Mortality; Mycobacterium tuberculosis; Paediatric; Shortage; Shortfall; Tuberculosis.

PubMed Disclaimer

References

    1. World Health Organization. Reported Estimates of BCG Coverage. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsc.... Accessed 23 Dec 2015.
    1. World Health Organization . Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form. Geneva: WHO; 2014.
    1. World Health Organization. Immunization Standards: BCG (10/20 dose vial). http://www.who.int/immunization_standards/vaccine_quality/118_bcg/en/. Accessed 30 Dec 2015.
    1. United Nations Children’s Emergency Fund. BCG Vaccine: Current Supply & Demand Outlook (September 2013). http://www.unicef.org/supply/files/BCG_Supply_Status_Sept_2013.pdf. Accessed 15 June 2015.
    1. United Nations Children’s Emergency Fund. BCG Vaccine: Current Supply & Demand Outlook (December 2014). http://www.unicef.org/supply/files/BCG_Supply_Status_December_2014.pdf. Accessed 15 June 2015.